Patrick TricoliCEO Nanobiotix USA and Executive VP, Global Head of BD at Nanobiotix USA
Patrick Tricoli is the current CEO of Nanobiotix Corp., the Nanobiotix US affiliate in Cambridge (MA) and EVP, Global Head of Business Development for the company. Patrick has built the Nanobiotix US presence, beginning in 2014, while cultivating cross-industry relationships.
Prior to Nanobiotix Patrick was well known for his lead roles at Sanofi in Partnering and Innovation R&D, and subsequently Head of External Innovation Europe, spanning 15 years, Europe, Asia, and the US markets where he led multiple teams in developing strong international BD relationships, Corporate Development strategies, and collaborative R&D partnership.
Patrick Tricoli ‘s background is R&D academic and industry including the Medical Research Division of Lederle Pearl River NY -today Pfizer- before he joint Synthélabo in 1991.
He also currently serves as a Foreign Trade Advisor New England for the French government since 2017 and as President of Curadigm Advisory Board.
Patrick is a Pharm D, Master in Pharmacology and Pharmacokinetic and Executive MBA from ESCP Europe.